Six years after his Alzheimer’s diagnosis, 90-year-old Zelik (Zel) Bocknek refuses to slow down — and he believes his active lifestyle is key to keeping his symptoms at bay. Bocknek, a retired ...

Hallucinations are a fairly common symptom in the advanced stages of Alzheimer’s disease. Treatment options like medications or therapy can help reduce their frequency and effect. Alzheimer’s ...

In a small early trial using a transcranial magnetic stimulation procedure, scientists were able to target a key brain ...

Professor Selina Wray and Dr Ashvini Keshavan (UCL Queen Square Institute of Neurology) help examine the decisions of regulatory bodies to use Lecanemab and Donanemab in the NHS.

Researchers have found that a compound derived from used coffee beans shows promise in protecting brain cells from damage ...

Find out what AI has already brought to Alzheimer's disease research and most importantly, what it can accomplish in the ...

Researchers at the University of California San Diego have found that high levels of an enzyme called PHGDH in the blood may ...

This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are ...

The Alzheimer's Association says more than 122,000 Missourians 65 years and older are battling Alzheimer's Disease, which has ...

The ability to possibly detect Alzheimer’s disease before symptoms emerge using blood-based biomarkers has introduced new ...

New treatments for Alzheimer disease don’t reverse cognitive symptoms, but they do significantly slow progression. Evidence suggests that earlier treatment is most effective.

A compassionate, multidisciplinary approach can help manage one of the most complex challenges nursing homes and other long-term care providers face.